Vinorelbine in Unresectable or Metastatic Esophageal and Gastric Adenocarcinoma
Status:
Completed
Trial end date:
2005-08-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to collect anti-tumor activity of vinorelbine when given to
patients with esophageal or gastric tumors. We will also collect information on the
toxicities of vinorelbine in these patients.
Phase:
Phase 2
Details
Lead Sponsor:
Dana-Farber Cancer Institute
Collaborators:
Beth Israel Deaconess Medical Center Brigham and Women's Hospital Massachusetts General Hospital